Top compounds associated with response to MT-ND2


Feature Type Standardized
Nominal ANOVA
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.078 0.04
mRNA clofarabine CTRPv2 pan-cancer AAC -0.064 0.04
mRNA ABT-263 CTRPv2 pan-cancer AAC -0.078 0.04
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.079 0.04
mRNA PF-184 CTRPv2 pan-cancer AAC -0.073 0.04
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC -0.078 0.04
mRNA triptolide CTRPv2 pan-cancer AAC 0.075 0.05
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.073 0.05
mRNA BRD-A05715709 CTRPv2 pan-cancer AAC -0.12 0.05
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.072 0.05
Download CSV